Summit Partners Public Asset Management, LLC Harrow Health, Inc. Transaction History

Summit Partners Public Asset Management, LLC

$2.79 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$4.6 - $7.88 $2.28 Million - $3.9 Million	-495,267 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.89 - $8.0 $480,858 - $786,680	98,335 Added 24.77%	495,267 $2.78 Million
Q2 2019 Aug 14, 2019	BUY	$4.2 - $8.7 $1.67 Million - $3.45 Million	396,932 New	396,932 $3.45 Million

Others Institutions Holding HROW

# of Institutions

177

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

Opaleye Management Inc. Boston, MA

3.99M
Shares

$140 Million
32.75% of portfolio
Private Capital Management, LLC Naples, FL

2.16M
Shares

$75.9 Million
11.41% of portfolio
Black Rock Inc. New York, NY

2.15M
Shares

$75.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.87M
Shares

$65.5 Million
0.0% of portfolio
State Street Corp Boston, MA

731K
Shares

$25.6 Million
0.0% of portfolio

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $950M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account